Tag :

pharmaceutical Press Releases

Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018

Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018

Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced today that it will report financial results for the first quarter of fiscal 2018 ended December 31, 2017, prior to the market opening on Tuesday, February 13, 2018. If there…

From Phoenix to Montreal: Acclaimed Futurist to Speak at Eleven Events in the Month of February

From Phoenix to Montreal: Acclaimed Futurist to Speak at Eleven Events in the Month of February

Following an event-filled January, futurist Jack Uldrich announced his February schedule of events throughout the United States and Canada. He will be presenting his insights on the future of a variety of industries, including pharmaceuticals, real estate, transportation, healthcare, agriculture, financial services, global…

BioBridges Promotes Mary Bielefeld to Senior Financial Analyst

BioBridges Promotes Mary Bielefeld to Senior Financial Analyst

BioBridges, a Career Portfolio® Management company providing integrated services to the life sciences community, proudly announces the promotion of Mary Bielefeld to senior financial analyst. Mary joined the BioBridges community as an accounting assistant in 2014 and most recently held…

Parnell Appoints Tony G Hartnell AM to Board of Directors

Parnell Appoints Tony G Hartnell AM to Board of Directors

Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced the appointment of Anthony G Hartnell AM to its Board of Directors. “We are indeed fortunate…

BASi Continues Profitability Improvement to Close Out Fiscal 2017

BASi Continues Profitability Improvement to Close Out Fiscal 2017

Bioanalytical Systems, Inc. (NASDAQ:BASI) (" BASi" or the "Company") today announced financial results for the three and twelve months ended September 30, 2017. Fourth Quarter Results For the three months ended September 30, 2017, revenue amounted to $5,873,000, a 14%…

Qualgen Has Partnered With Salvation Army to Help Those in Need

Qualgen Has Partnered With Salvation Army to Help Those in Need

Qualgen has partnered with the Salvation Army in assisting those in need. This includes those affected by Hurricane Harvey, Hurricane Irma and those in need this holiday season. “We wanted to make sure that 100 percent of all contributions made…

Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017

Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017

Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it will report financial results for the fourth quarter and twelve months ended September 30, 2017, prior to the market opening on Tuesday, December 19, 2017. If there are…

George Clinical Promotes Matthew Reabold, Sr., to Head of Business Development, USA

George Clinical Promotes Matthew Reabold, Sr., to Head of Business Development, USA

George Clinical, a leading full-service CRO in the US and Asia-Pacific region, is pleased to announce that Matthew Reabold, Sr. has been promoted to the Head of Business Development, USA. George Clinical, headquartered in Sydney, Australia, operates in 15 countries around the world and…

BioBridges Promotes Christopher DeMaina to Vice President of Client Services

BioBridges Promotes Christopher DeMaina to Vice President of Client Services

​BioBridges, a Career Portfolio® Management company providing integrated services to the life sciences community, proudly announces the promotion of Christopher DeMaina to Vice President of Client Services. Chris has served as BioBridges’ Director of Client Services for the past four…

Comply FDA names new Editor-in-Chief

Comply FDA names new Editor-in-Chief

Comply FDA has named Michael Kuehne as their new editor in chief. Mr. Kuehne is an industry leader with more than twenty years' experience in the areas of quality and compliance for life science organizations.Under Mr. Kuehne' s supervision, Comply…

Leading UK Drug Developer RxCelerate Opens First US Base in Boston

Leading UK Drug Developer RxCelerate Opens First US Base in Boston

RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today it has hired Laura Hamilton as Executive Vice President, U.S. Operations and opened an office in Cambridge, Massachusetts, just outside Boston. “We are bringing…

PetLife Pharmaceuticals Announces Haiti Veterinary Initiative

PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the “Company”), a developer of a new generation of high- potency veterinary cancer medications and nutraceuticals for pets, through its subsidiary, PetLife Pharma International, Inc. (collectively “PetLife”), and in cooperation with Elite International Partners (“Elite”), announces…

Unique Meeting in London to Shift Focus From Treatment to Prevention of Disease

Unique Meeting in London to Shift Focus From Treatment to Prevention of Disease

The program for the first assembly of the World Congress on Targeting Metabesity is now available at www.metabesity2017.com. Metabesity refers to the major public health challenges—cardiovascular disease, cancer, dementia, diabetes and the aging process itself—all of which share metabolic roots. These…

Innovo Research to Begin Clinical Trials Through Nationwide Network

Innovo Research to Begin Clinical Trials Through Nationwide Network

Innovo Research (www.innovoresearch.com), a new venture created by Wilmington Health (Wilmington, North Carolina) and Christie Clinic (Champaign, Illinois), and in partnership with QuintilesIMS, has launched to advance medical research across the country. Now pharmaceutical companies around the world can work…

Microbiome Therapeutics Market, 2015 – 2030

The term "microbiota" refers to specific clusters of commensal, symbiotic and pathogenic microorganisms that reside in various regions on and within the human body. The human microbiome is involved in various functions that are essential to lead a healthy life.…

BioBridges Announces Corporate Sponsorship of Battle of the Biotech Bands

BioBridges Announces Corporate Sponsorship of Battle of the Biotech Bands

BioBridges, a Career Portfolio® Management company providing integrated services to the life sciences community, is excited to announce its corporate sponsorship of the upcoming fourth annual Battle of the Biotech Bands (BoBB). Proceeds from the event will benefit charitable foundations…

Mapping the Rise of Non-Invasive Cancer Diagnostics

Roots Analysis has announced the addition of "Non-Invasive Cancer Diagnostics Market (2nd Edition), 2017-2030" report to its list of offerings. The report provides a comprehensive analysis of the current landscape and future outlook of the growing market of liquid biopsy…

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017

Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced an update on business results including strong revenue growth of 25% to $10.3 million, substantial improvement…

Cell Therapy Manufacturing Market Well Set to Meet Exponential Demand

Roots Analysis has announced the addition of "Cell Therapy Manufacturing Market, 2017-2027" report to its list of offerings. The report provides an extensive study on the current landscape of the rapidly growing market of cell therapy manufacturing and focuses both…

New Generation Antibacterials to Witness Annualized Growth of Over 30%, reports Roots Analysis

Roots Analysis has announced the addition of "Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026" report to its portfolio. The report provides an extensive study of the market current landscape and the growing pipeline of new generation antibiotics…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login